Cardlytics, Inc.
For the period ended Jun 30, 2026. Filed Aug 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (Unaudited)
(Amounts in thousands, except par value amounts)
| June 30, 2026 | December 31, 2025 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $28,039 | $48,719 |
| Accounts receivable and contract assets, net | 67,644 | 82,458 |
| Other receivables | 2,855 | 2,474 |
| Prepaid expenses and other assets | 2,533 | 3,213 |
| Current assets of discontinued operations | — | 415 |
| Total current assets | 101,071 | 137,279 |
| Long-term assets: | ||
| Property and equipment, net | 1,617 | 1,931 |
| Right-of-use assets under operating leases, net | 4,096 | 4,723 |
| Goodwill | 110,305 | 110,305 |
| Capitalized software development costs, net | 16,577 | 19,005 |
| Other long-term assets, net | 1,119 | 1,235 |
| Noncurrent assets of discontinued operations | — | 11,163 |
| Total assets | $234,785 | $285,641 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $1,245 | $2,655 |
| Accrued liabilities: | ||
| Accrued compensation | 4,828 | 6,038 |
| Accrued expenses | 12,320 | 7,125 |
| Partner Share liability | 18,503 | 24,792 |
| Consumer Incentive liability | 21,812 | 32,144 |
| Deferred revenue and other liabilities | 2,194 | 2,541 |
| Current operating lease liabilities | 1,448 | 1,438 |
| Current liabilities of discontinued operations | — | 1,657 |
| Total current liabilities | $62,350 | $78,390 |
| Long-term liabilities: | ||
| Convertible senior notes, net | $169,411 | $168,850 |
| Lines of credit | 15,000 | 40,070 |
| Long-term operating lease liabilities | 4,028 | 4,748 |
| Long-term liabilities of discontinued operations | — | 91 |
| Total liabilities | $250,789 | $292,149 |
| Stockholders’ deficit: | ||
| Common stock, $0.0001 par value—10,000 shares authorized and 5,808 and 5,451 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively.(1) | $10 | $10 |
| Additional paid-in capital | 1,408,082 | 1,399,542 |
| Accumulated other comprehensive loss | (676) | (1,996) |
| Accumulated deficit | (1,423,420) | (1,404,064) |
| Total stockholders’ deficit | (16,004) | (6,508) |
| Total liabilities and stockholders’ deficit | $234,785 | $285,641 |
(1)The number of shares of common stock has been adjusted for the prior period presented to reflect the one-for-ten reverse stock split effected on June 5, 2026. See Note 2 -Significant Accounting Policies and Recent Accounting Standards for more information.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.